How Can Pulmonologists Help Improve Treatment Outcomes in Patients With Advanced NSCLC?

Image

This brief publication discusses current standards for the initial evaluation of newly diagnosed, advanced NSCLC; recommended first-line therapy for advanced NSCLC; and requirements and recommendations for biomarker analysis to guide treatment planning and initiation in affected patients.

Format
Online Publication
Cost
Complimentary
Credit
0.25 AMA PRA Category 1 Credit™

Thomas Eldridge Stinchcombe, MD
Professor of Medicine
Division of Medical Oncology
Duke University School of Medicine